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Background: Aflatoxin B1 (AFB1) is a mycotoxin produced by Aspergillus spec. The latter are worldwide contaminants
of food with mutagenic and carcinogenic activities in animals and humans. AFB1 was shown to have deleterious
effects on metabolism of eukaryotes in many model systems, including the ability to inhibit DNA replication. An agent
that disturbs DNA replication may also have the potential to induce de novo DNA copy number variations (CNVs).
Results: Blood samples of three clinically healthy carriers were treated in vitro with AFB1 and chromosome
preparations were subjected to parental origin determination fluorescence in situ hybridization (pod-FISH). Probes
able to visualize CNVs in 8p21.2 and 15q11.2 were applied. In this setting here for the first time an influence of
AFB1 on molecular-cytogenetically detectable CNVs could be shown.
Conclusions: The obtained results indicate that: (i) pod-FISH is a single cell directed, sensitive and suitable method
for the analysis of mutagen induced CNVs, (ii) AFB1 has the potential to induce in vitro instability of known CNVs in
human leukocytes.
Keywords: Aflatoxin B1, Mycotoxins, Copy number variation, Parental origin determination fluorescence in situ
hybridization (pod-FISH)Background
Aflatoxins are mycotoxins produced by Aspergillus
flavus and Aspergillus parasiticus, which are common
food contaminants [1,2]. The most important aflatoxin
in terms of toxic potency and occurrence is aflatoxin B1
(AFB1), which is also considered as strong carcinogen
[3,4]. Studies on the mutagenic effects of AFB1 have
shown that it induces chromosomal aberrations in hu-
man cells [5-7]. Besides it also acts on DNA level: AFB1
treatment e.g. causes transversion of G/T in 249 codon
of the TP53 gene in human hepatocytes [8]. However,
mutational spectrum induced by AFB1 requires further
investigation.
DNA copy number variations (CNVs) are defined as
stretches of DNA segments ranging in size from one
kilobase pair to several megabase pairs when studying
different individuals and/or different tissues of an indi-
vidual. CNVs may occur both in clinically normal and* Correspondence: rouben_a@hotmail.com
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unless otherwise credited.affected subjects [9,10]. Up to 12% of genome is consti-
tuted by CNVs, which can arise both meiotically and
mitotically [11,12]. CNVs in the normal population, have
recently gained considerable interest as a source of
genetic diversity. At the same time it is clear that many
CNVs have deleterious consequences. Spontaneous or de
novo CNVs are an important cause of genetic and devel-
opmental disorders, and they also arise frequently in
cancer cells [13-15]. Despite their huge impact on
human polymorphism and diseases, still little is known
about environmental factors which may induce de novo
CNVs. Recently the involvement of replication stress
inducers (aphidicolin, hydroxyurea, low-dose ionizing
radiation) in CNVs formation was shown [16-18]. The
ability of different mycotoxins, including AFB1, to in-
hibit DNA synthesis in mammalian cells was revealed
earlier [19-23], but their possible implication in CNVs
formation was not yet studied in detail.
Here we describe the influence of AFB1 on earlier
reported cytogenetically visible CNVs of 8p21.2 and
15q11.2 [24,25] in human peripheral blood leukocytes
using CNV-specific bacterial artificial chromosomesentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Fluorescence intensities of signals in chromosome
regions 8p21.2 and 15q11.2 in AFB1-treated human leukocytes.
Fluorescence intensities in chromosome regions 8p21.2 and 15q11.2
were measured in 150 metaphases for each loci by Scion Image
program. AFB1 decreased mean values of fluorescence intensities of
signals in regions 8p21.2 and 15q11.2 in comparison with controls
(Mann-Whitney W-test, *p < 0.05).
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fluorescence in situ hybridization (pod-FISH) [26].
Results
Human peripheral blood lymphocytes of three clinically
healthy individuals were used for analysis of influence of
AFB1 on CNVs in chromosomal regions 8p21.2 and
15q11.2 using the pod-FISH approach [26]. Fluorescence
intensities of signals reflecting the sizes of the CNVs
were compared between homologous chromosomes in
each metaphase as well as between treated and un-
treated samples (see below in Methods part “Statistical
analysis”).
Evaluation of differences in CNVs signals intensities
between homologous chromosomes in each metaphase
spread by Chi-square test (Figure 1) indicated for the
ability of AFB1 to affect the analysed chromosomal
regions. Statistically significant (p < 0.05) increase in
percentage of metaphases with significantly different
signals in region 15q11.2 (48.75% and 58.9% after 24 and
48 hours of AFB1 treatment, respectively) compared
with control (33.45%) was shown (Figure 1). In region
8p21.2 we found only a statistic trend toward instability
after 48 hours of AFB1 treatment (51.3%).
Kolmogorov-Smirnov test revealed that the distribu-
tion of signals intensities of chromosome regions 8p21.2
and 15q11.2 is non-normal, which precludes the use of
parametric tests. Thus, nonparametric Mann-Whitney
W-test was applied for comparison of CNVs between
AFB1-treated and untreated cells (Figure 2). Analysis of
obtained results revealed that AFB1 induced decrease in
signals intensities in the selected chromosome regions
compared to control. Namely, the levels of CNVs were
significantly (p < 0.05) decreased in region 8p21.2 afterFigure 1 Percentage of metaphases with significantly different
signals in 8p21.2 and 15q11.2 in AFB1-treated human leukocytes.
Fluorescence intensities of signals in chromosome regions 8p21.2 and
15q11.2 were measured in 150 metaphases for each loci by Scion
Image program. AFB1 induced statistically significant increase in
metaphases with significant differences in CNVs signals between
homologous chromosomes in region 15q11.2 in comparison with
control (Chi-square test, *p < 0.05).24 (206 a. u.) and 48 hours (200 a. u.) and in 15q11.2
after 24 hours (180 a. u.) of AFB1 treatment in compari-
son with controls (216 a. u. and 187 a. u., respectively).
Tendency to decrease was also observed in 15q11.2 of
AFB1-treated cells after 48 hours (182 a. u.).
Overall, we provide the first evidence of AFB1-induced
instability in two CNV loci of human genome. Decrease
of the size of CNV loci permitted to suggest that the
instability might occur mainly due to deletions in the
studied regions.
Discussion
There are many publications related to analysis of spon-
taneous CNVs in human population [9,13,15]. However,
little is known about the induction of de novo CNVs by
environmental risk factors [16].
The main sources of CNVs are duplications and dele-
tions, and there are different models that explain mo-
lecular mechanisms of these processes. Change in copy
number involves change in the structure of the chro-
mosomes which occur by two general mechanisms,
nonhomologous end joining, along with homologous
recombination [11]. Both of these mechanisms are in-
volved in repair of arrested replication forks that in-
clude a double strand break [27,28]. Different studies
have shown that inhibitors of replication may induce
CNVs experimentally in human cells [17,29]. Particu-
larly, the DNA polymerase inhibitor aphidicolin and
replication inhibitor, hydroxyurea were correlated
positively with increased induction of CNVs incidence
in somatic cells cultured in vitro [16].
Earlier it was shown that AFB1 is mutagenic in many
model systems and produces chromosomal aberrations,
micronuclei, sister chromatid exchange, unscheduled DNA
synthesis, and DNA strand breaks, as well as forms adducts
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predominant AFB1–DNA adduct AFB1–N 7-Gua act as
replication blocks [31,32]. Based on this information, the
purpose of this study was to determine the ability of AFB1
influence on CNVs level in human blood cells in vitro.
The data of our study show that AFB1 impacts CNVs
located at chromosome loci 8p21.2 and 15q11.2 in
human peripheral blood leukocytes. Significant increase
of differences in the sizes of the CNVs between homolo-
gous chromosomes was revealed in AFB1-treated cells
compared with control. The fluorescence intensities of sig-
nals in blood leukocytes decreased after AFB1 treatment in
the most cases, indicating deletions in 8p21.2 and 15q11.2.
Earlier in AFB1-exposed hepatocellular carcinoma’s cases
homozygous deletions at different loci were reported [33]
including chromosome regions 8p23 and 15q25-26 adja-
cent to the areas studied in our work [34-36].
CNVs analysis was based on a comparison of fluores-
cence intensities in 8p21.2 and 15q11.2 between hom-
ologous chromosomes as well as between AFB1-treated
and untreated samples. This approach permits to detect
unequal loss or gain and does not allow recognizing de-
letions or duplications of similar size occurred simultan-
eously in the compared loci. Thus, our results can be
considered as underestimated but even so, they do indi-
cate the effect of AFB1 on CNVs.
Taking into consideration the fact that AFB1 is a world-
wide contaminant of food its effect on the CNVs in hu-
man genome can be quite substantial. Further studies of
AFB1-promoting copy number change are warranted to
shed light on de novo induced CNVs formation.
Conclusions
In conclusion, our preliminary results indicate that AFB1
can induce instability in CNV regions in chromosome loci
8p21.2 and 15q11.2 in human leukocytes culture. It wasFigure 3 Sample of evaluation of signal intensities by Scion Image pr
were done on homologous chromosomes of 15q11.2 (A) and 8p21.2 (B) a
for chromosome region 15q11.2 and RP11-115K10 for chromosome regionrevealed that instability is a consequence of deletions in
analyzed regions. This first study on influence of AFB1 on
CNVs in human blood leukocytes requires further system-
atic trials in future.
Methods
Blood cultivation and treatment with aflatoxin B1
Blood samples were collected from three healthy vol-
unteers – two female and one male aged 24-26 years.
The study was approved by the Ethics Committee of the
Institute of Molecular Biology of National Academy of
Sciences of RA (IRB # IORG 0002437), and informed
consent was obtained from all study donors. The
venous blood (5 ml from each donor) was collected
into syringe with heparin (0.5 ml) and incubated in
50 ml of RPMI-1640 medium, containing 10% foetal
bovine serum, 1% penicillin/streptomycin, and 10 μg/ml
phytohemagglutinin-L at 37°C. The cells were treated with
AFB1 (Sigma - A6636) dissolved in 96% ethanol 24 and
48 hours after cultures initiation. The final concentration
of AFB1 in the cultures was 3 μg/ml. Due to the limited
publications on de novo induced CNVs the AFB1-treating
model was developed based on the data on chromosomal
aberrations [5-7,37] and personal experimental results.
Metaphase chromosome preparation
Metaphase chromosomes were prepared according to
Bangs and Donlon [38]. Colcemid (0.1 μg/ml final concen-
tration) was added to the culture 2 hours before harvest-
ing and incubated at 37°C to achieve metaphase block. In
total, blood cultures were incubated for 72 hours at 37°C.
At the end of cultivation cells were harvested and centri-
fuged at 1500 rpm (10 min). The medium was removed
completely except for about 0.5 ml of supernatant
remaining above the cell pellet. 10 ml of pre-warmed
(37°C) hypotonic solution (0.075 M KCl) was added toogram (highlighted by arrows). Signals intensities measurements
fter incubation with AFB1 in a. u. CNV-specific BAC probes RP11- 79C23
8p21.2 were applied.
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bated for 15 minutes at 37°C. Then a few drops of
freshly prepared fixative (methanol/glacial acetic acid,
3:1) were added and inverted to mix. After centrifugation
and discarding supernatant cells were fixed by 10 ml of
ice-cold fixative. After incubation 10-15 minutes at room
temperature the cells were centrifuged, supernatant was
discarded and 10 ml of fixative was added. After the last
centrifugation, cells were resuspended in a small amount
of fixative and the suspension was dropped onto a micro-
scope slide, prewashed by fixative. Then the slide was
placed on hotplate (51°C) covered by wet tissue paper and
kept until the surface of the slide was dried.
Parental origin determination fluorescence in situ
hybridization (pod-FISH) has already been successfully
used to identify CNVs in human cells [39]. BAC clones
from CNV regions were selected by the “Database of
Genomic Variants” (http://dgv.tcag.ca/dgv/app/home),
purchased from the Children’s Hospital Oakland Research
Institute (CHORI), Oakland, CA, USA, or kindly provided
by the Sanger Centre, UK. BAC DNA was isolated,
PCR amplified, and labeled by nick translation (Roche,
Karlsruhe, Germany) [26]. The following BACs were used:
RP11-115K10 and RP11-79C23 for 8p21.2 (Spectrum-
Green) and 15q11.2 (SpectrumGreen) regions, respect-
ively. Image capturing and acquisition were processed
with the Isis imaging system (MetaSystems, GmbH,
Altlussheim, Germany). For analysis of pod-FISH sig-
nals the freeware SCION (http://scion-image.software.
informer.com/) (Figure 3) was applied [40]. For that
purpose images were converted to grayscale and fluor-
escence intensities of signals were measured from 150
metaphases for each region and expressed in arbitrary
units (a. u.).
Statistical analysis
The normality of distribution of FISH signals intensity
was analysed by the Kolmogorov-Smirnov test (was
confirmed by analysis of standardized skewness and
standardized kurtosis). Chi-square test was applied to
analyze the significance of difference of homologous chro-
mosomes signals. First, in every metaphase the signal in-
tensities of homologous chromosomes were compared
with each other separately. Second, the obtained quantity
of significantly different measurements of signals for each
variant in percents was compared to estimate the influ-
ence of AFB1 on CNVs. Mann-Whitney W-test (nonpara-
metric test) was applied for determination of difference
between treated and untreated groups.
Chi-square test was performed using online interactive
calculator [41]. Mann-Whitney W-test was performed
using the statistical package Statgraphics 16.2. A prob-
ability level at p < 0.05 was considered as statistically
significant.Competing interests
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